Recall archive / FDA drug enforcement
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, ... — FDA record D-1167-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Apr 15, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
- Reason
- Subpotent drug
- Classification
- Class I
- Recalling firm
- Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
- Quantity
- 1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles
- Agency-reported status
- Terminated
- Source record identifier
- D-1167-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: 03312022@29, BUD: 6/10/2022 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
CA
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Jun 15, 2022
- Recall initiation date
- Apr 15, 2022
- Center classification date
- Jun 27, 2022
- Termination date
- Nov 7, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.